Campo J M, Nijman H, Evers C, Merckelbach H L, Decker I
Mondriaan Zorggroep, Postbus 4436, 6401 CX Heerlen.
Ned Tijdschr Geneeskd. 2001 Sep 29;145(39):1876-80.
In the Netherlands it has recently become possible for transsexual patients to receive hormonal treatment from the onset of puberty. Until the age of 16, pubertal development can be prevented with luteinizing hormone-releasing hormone (LHRH) agonists. From 16 years of age onwards, gender adjustment can be initiated by administration of hormones of the opposite sex. Surgical treatment can be offered once the patient reaches 18 years of age. Although such treatment will only be initiated with reticence and after a long phase of intense diagnostic screening, the question arises whether a clear differentiation can be made between pure gender identity disorders and secondary transsexual feelings that are part of an ongoing psychopathological development, such as schizophrenia. The potential diagnostic confusion is illustrated by a case history of a male schizophrenic patient. This patient had been treated hormonally for transsexualism for years before acute psychotic decompensation occurred. Neuroleptic treatment of the psychosis rapidly reduced the psychotic symptoms. In retrospect, the patient regards his transsexual period as a 'mistake'. Delusions about one's physical appearance and the urge to drastically change the way one looks appear to be relatively common in patients suffering from schizophrenia.
在荷兰,变性患者从青春期开始就有可能接受激素治疗。在16岁之前,可用促黄体生成素释放激素(LHRH)激动剂阻止青春期发育。从16岁起,可通过给予异性激素来启动性别调整。患者年满18岁后可进行手术治疗。尽管这种治疗只会在经过长时间深入的诊断筛查且谨慎的情况下才会开始,但问题是,能否在单纯的性别认同障碍与作为精神病理发展过程一部分的继发性变性情感(如精神分裂症)之间做出明确区分。一名男性精神分裂症患者的病史说明了潜在的诊断混淆情况。该患者在急性精神病性失代偿发生前多年一直接受变性激素治疗。对精神病进行抗精神病药物治疗迅速减轻了精神病症状。回顾往事,该患者将其变性时期视为一个“错误”。对自己外貌的妄想以及彻底改变外貌的冲动在精神分裂症患者中似乎相对常见。